Congratulations to everyone at Neuren for pursuing this drug development and to those at Acadia who decided to take on the risk of funding the Ph III trials and putting it up for approval. Congrats to the long term shareholders who ignored the noise from others and stuck with this. I've been in it since 2013 and decided to sell out of a few other companies on Thurs to be able to tip some more into NEU @ $7.65. I reckon it will turn out to be one of the best investments I've ever made. I think NEU is going to suddenly become extremely overweight in my portfolio.
Disclosure status changed from Hold to Hold Tightly.
Congratulations to everyone at Neuren for pursuing this drug...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.05 |
Change
-0.510(3.50%) |
Mkt cap ! $1.795B | |||
| Open | High | Low | Value | Volume |
| $14.38 | $14.42 | $13.94 | $6.419M | 454.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $13.99 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.07 | 6644 | 4 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NEU (ASX) Chart |